Science and society: Advocacy groups as research organizations: the PXE International example

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Nature reviews genetics

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1038/nrg1991
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• The commercial roots of the genomic commons

  2025cites this paper
• Chronically ill patients’ perspectives on support services and activities of patient organizations

  2024cites this paper
• Categorical misalignment: Making autism(s) in big data biobanking

  2024cites this paper
• Reiterated Fact-Making: Explaining Transformation and Continuity in Scientific Facts

  2024cites this paper
• Making patients political: Narrating, curating, enacting, and navigating the 'idealised policy patient'.

  2023cites this paper
• Virtual Trials: Causally-validated treatment effects efficiently learned from an observational cancer registry

  2022cites this paper
• The practice of active patient involvement in rare disease research using ICT: experiences and lessons from the RUDY JAPAN project

  2021cites this paper
• Broadening Participation: 21st Century Opportunities for Amateurs in Biology Research.

  2021cites this paper
• Integrative and Comparative Biology

  2021cites this paper
• Genetic heterogeneity of heritable ectopic mineralization disorders in a large international cohort.

  2021cites this paper
• Exploring collective consumer innovation in health care: Cases and formal modeling

  2021cites this paper
• The Human Face of ABCC6

  2020cites this paper
• The reported impact of public involvement in biobanks: A scoping review

  2020cites this paper
• Dual organizational identification within multisite nonprofit organizations

  2020cites this paper
• Landscape of Participant-Centric Initiatives for Medical Research in the United States, the United Kingdom, and Japan: Scoping Review

  2020cites this paper
• The use of human biospecimens for research

  2020cites this paper
• Examining Physician Interactions with Disease Advocacy Organizations

  2019cites this paper
• Landscape of Participant-Centric Initiatives for Medical Research in the United States, the United Kingdom, and Japan: Scoping Review (Preprint)

  2019cites this paper
• Donors, authors, and owners: how is genomic citizen science addressing interests in research outputs?

  2019cites this paper
• The role of patient organizations in the rare disease ecosystem in India: an interview based study

  2019cites this paper
• An open science rare diseases research initiative: the University of North Carolina Catalyst

  2019cites this paper
• The Genomic Commons.

  2018cites this paper
• Research as an event: a novel approach to promote patient-focused drug development

  2018cites this paper
• Evaluating the impact of patient and public involvement on cancer research outcomes : a UK mixed methods study

  2018cites this paper
• Signaling valuable human capital: Advocacy group work experience and its effect on employee pay in innovative firms

  2018cites this paper
• Citizen science, public policy

  2018cites this paper
• Innovating for the Better? The Role of Advocacy Group Work Experience for Employee Pay

  2018cites this paper
• Chasing cures: Rewards and risks for rare disease patient organisations involved in research

  2018cites this paper
• Needs and Requirements of Modern Biobanks on the Example of Dystonia Syndromes

  2017cites this paper
• A critique of the regulation of data science in healthcare research in the European Union

  2017cites this paper
• Chasing cures: Rewards and risks for rare disease patient organisations involved in research

  2017cites this paper
• Consuming DNA: The Good Citizen in the Age of Precision Medicine

  2017cites this paper
• The Importance of Research Data Sharing: The Meeting Reports Section of the JID.

  2017cites this paper
• ABCC6 and Pseudoxanthoma Elasticum: The Face of a Rare Disease from Genetics to Advocacy

  2017influential citation
• Patient, caregiver and clinician views on engagement in comparative effectiveness research.

  2017cites this paper
• Addressing Deficits and Injustices: The Potential Epistemic Contributions of Patients to Research

  2017cites this paper
• A qualitative study on acceptable levels of risk for pregnant women in clinical research

  2017cites this paper
• Patient engagement in the design and execution of urologic oncology research.

  2017cites this paper
• New Recommendation on Biological Materials Could Hamper Muscular Dystrophy Research

  2016cites this paper
• The involvement of patient organisations in rare disease research: a mixed methods study in Australia

  2016cites this paper
• Coordinated Exploration for Grand Challenges: The Role of Advocacy Groups in Search Consortia

  2016cites this paper
• Dermatology's Researchers of the Future: Our Workforce Pipeline and Richest Opportunities.

  2016cites this paper
• Review of patient registries in dermatology.

  2016cites this paper
• New modes of engagement for big data research

  2016cites this paper
• Consulting, Mediating, Conducting, and Supporting: How Community-Based Organizations Engage With Research to Influence Policy

  2016cites this paper
• Policy ideas through the prism of knowledge regimes and framing

  2016cites this paper
• Toward an Affirmative Biopolitics

  2016cites this paper
• Within and beyond the communal turn to informed consent in industry-sponsored pharmacogenetics research: merits and challenges of community advisory boards

  2016cites this paper
• Patient and Stakeholder Engagement in the PCORI Pilot Projects: Description and Lessons Learned

  2015cites this paper
• Broad Consent for Research With Biological Samples: Workshop Conclusions

  2015cites this paper
• Molecular Genetics of Heritable Skin Diseases: Pseudoxanthoma Elasticum as a Paradigm of China-US Collaboration.

  2015cites this paper
• Data monitoring committees for pragmatic clinical trials

  2015cites this paper
• Translating rare-disease therapies into improved care for patients and families: what are the right outcomes, designs, and engagement approaches in health-systems research?

  2015cites this paper
• Current trends in biobanking for rare diseases: a review [Corrigendum]

  2015cites this paper
• Involving Patients in Reducing Decision Uncertainties Around Orphan and Ultra-Orphan Drugs: A Rare Opportunity?

  2015cites this paper
• ReseArch with Patient and Public invOlvement: a RealisT evaluation – the RAPPORT study

  2015cites this paper
• Patient representation and the research agenda in neurodegenerative disease

  2015cites this paper
• Bardet–Biedl syndrome: A model for translational research in rare diseases

  2015cites this paper
• Narratives of Participation in Autism Genetics Research

  2015cites this paper
• Community-engaged approaches to explore research priorities in Duchenne and Becker muscular dystrophy

  2015cites this paper
• Biobanks, Data Sharing, and the Drive for a Global Privacy Governance Framework

  2015cites this paper
• Policy ideas through the prism of knowledge regimes and framing

  2015cites this paper
• Disentangling Public Participation In Science and Biomedicine

  2014cites this paper
• A consumer adoption model for personalized medicine: an exploratory study

  2014cites this paper
• Families’ experiences with medical research for pediatric rare diseases : a qualitative ethnographic study of parents and children participating in clinical trials for Duchenne muscular dystrophy (DMD)

  2014cites this paper
• Exploring the Positions of German and Israeli Patient Organizations in the Bioethical Context of End-of-Life Policies

  2014cites this paper
• Current trends in biobanking for rare diseases: a review

  2014cites this paper
• Heterogeneity, not randomness, sets challenges for quantitative genetics and epidemiology: A response to Davey Smith’s “gloomy prospect”

  2014cites this paper
• Expectations and experiences of investigators and parents involved in a clinical trial for Duchenne/Becker muscular dystrophy

  2014cites this paper
• UNIVERSITIES' ROLE IN PUBLIC HEALTH ADVOCACY:

  2014cites this paper
• Public Engagement - Promises, demands and fields of practice

  2014cites this paper
• The Role of Brain Tumor Advocacy Groups

  2014cites this paper
• Focusing on Cause or Cure? Priorities and Stakeholder Presence in Childhood Psychiatry Research

  2014cites this paper
• Translational informatics in personalized medicine: an update for 2014.

  2014cites this paper
• Duchenne / Becker muscular dystrophy Expectations and experiences of investigators and parents involved in a clinical trial for

  2014cites this paper
• Stakeholder views on returning research results.

  2013cites this paper
• Knowledge co-production in health research, policy and care practice

  2013cites this paper
• Ethical, legal, social, and policy implications of behavioral genetics.

  2013cites this paper
• Progress in Epidermolysis bullosa research: summary of DEBRA International Research Conference 2012.

  2013cites this paper
• Biobanking: The Melding of Research with Clinical Care

  2013cites this paper
• Warfarin accelerates ectopic mineralization in Abcc6(-/-) mice: clinical relevance to pseudoxanthoma elasticum.

  2013cites this paper
• ‘Information is information’: a public perspective on incidental findings in clinical and research genome‐based testing

  2013cites this paper
• An End to the Myth: There Is No Drug Development Pipeline

  2013cites this paper
• Pseudoxanthoma elasticum: progress in research toward treatment: summary of the 2012 PXE international research meeting.

  2013cites this paper
• Pseudoxanthoma elasticum: the paradigm of ectopic mineralization disorders – diagnosis and treatment

  2013cites this paper
• Chapter 147 – Epidermolysis Bullosa

  2013cites this paper
• Consent and community engagement in diverse research contexts.

  2013cites this paper
• The role of patient advocacy organizations in shaping genomic science.

  2013cites this paper
• Consent and Community Engagement in Diverse Research Contexts: Reviewing and Developing Research and Practice

  2013cites this paper
• American DNA

  2013cites this paper
• Disclosure of incidental genomic findings involving children: are we making progress?

  2013cites this paper
• Disease advocacy organizations catalyze translational research

  2013cites this paper
• Response to the commentary "Significance of patient registries for dermatological disorder".

  2013cites this paper
• Engaging Patients in Information Sharing and Data Collection: The Role of Patient-Powered Registries and Research Networks

  2013cites this paper
• Disease advocacy organizations catalyze translational

  2013cites this paper
• Ownership of Biomedical Information in Biobanks

  2013cites this paper
• US biobanking strategies and biomedical immaterial labor

  2012cites this paper
• The human side of cancer biobanking.

  2012cites this paper
• Genetic Counseling, Activism and ‘Genotype-First’ Diagnosis of Developmental Disorders

  2012cites this paper
• What is in a Clause

  2012cites this paper